2022 Q4 Form 10-Q Financial Statement

#000121390022072397 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $8.556M $4.100M $7.826M
YoY Change -34.87% -47.61% 11.32%
Cost Of Revenue $7.953M $2.792M $5.521M
YoY Change -12.22% -49.42% -6.74%
Gross Profit $603.3K $1.308M $2.305M
YoY Change -85.2% -43.27% 107.61%
Gross Profit Margin 7.05% 31.9% 29.46%
Selling, General & Admin $623.8K $7.660M $5.637M
YoY Change -87.44% 35.89% 124.25%
% of Gross Profit 103.4% 585.68% 244.52%
Research & Development $3.387M $321.0K $1.448M
YoY Change -0.1% -77.82% 42.14%
% of Gross Profit 561.41% 24.54% 62.79%
Depreciation & Amortization $7.913M $13.73K $1.031M
YoY Change 667.58% -98.67% 126.37%
% of Gross Profit 1311.61% 1.05% 44.72%
Operating Expenses $11.92M $9.003M $8.116M
YoY Change 27.0% 10.93% 103.52%
Operating Profit -$11.32M -$7.695M -$5.810M
YoY Change 113.07% 32.44% 101.95%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$6.160K $3.00 $36.74K
YoY Change -133.33% -99.99% -1380.14%
Pretax Income -$31.03M -$7.695M -$5.773M
YoY Change 486.01% 33.28% 100.57%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$31.03M -$7.695M -$5.773M
YoY Change 485.86% 33.28% 100.57%
Net Earnings / Revenue -362.62% -187.66% -73.77%
Basic Earnings Per Share -$0.22 -$0.25
Diluted Earnings Per Share -$0.65 -$0.22 -$247.1K
COMMON SHARES
Basic Shares Outstanding 47.36M shares 34.59M shares 23.37M shares
Diluted Shares Outstanding 34.65M shares 23.37M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $472.2K $368.3K $5.340M
YoY Change -69.8% -93.1% 10.17%
Cash & Equivalents $472.2K $368.3K $5.340M
Short-Term Investments
Other Short-Term Assets $279.7K $776.8K $1.084M
YoY Change -69.56% -28.32% -2.94%
Inventory
Prepaid Expenses $41.59K $232.2K
Receivables $1.650M $2956B $10.10M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.402M $4.101M $16.53M
YoY Change -82.42% -75.18% 31.08%
LONG-TERM ASSETS
Property, Plant & Equipment $85.43K $114.8K $167.7K
YoY Change -44.52% -31.53% -11.83%
Goodwill $5.578M $5.578M
YoY Change 0.0%
Intangibles $7.119M $11.75M
YoY Change -51.89%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $12.78M $17.45M $21.56M
YoY Change -37.73% -19.08% 70.71%
TOTAL ASSETS
Total Short-Term Assets $2.402M $4.101M $16.53M
Total Long-Term Assets $12.78M $17.45M $21.56M
Total Assets $15.18M $21.55M $38.09M
YoY Change -55.58% -43.43% 50.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.073M $3.783M $2.182M
YoY Change 121.17% 73.4% 110.0%
Accrued Expenses $2.186M $3.343M $91.57K
YoY Change 2287.77% 3550.57% -86.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.520M $7.315M $3.726M
YoY Change 63.44% 96.3% -47.54%
LONG-TERM LIABILITIES
Long-Term Debt $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% -98.05%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% -98.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.520M $7.315M $3.726M
Total Long-Term Liabilities $10.00K $10.00K $10.00K
Total Liabilities $7.530M $7.325M $3.736M
YoY Change 63.3% 96.04% -50.94%
SHAREHOLDERS EQUITY
Retained Earnings -$131.4M -$100.4M
YoY Change 59.77%
Common Stock $5.512K $3.685K
YoY Change 109.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.654M $14.22M $34.35M
YoY Change
Total Liabilities & Shareholders Equity $15.18M $21.55M $38.09M
YoY Change -55.58% -43.43% 50.92%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$31.03M -$7.695M -$5.773M
YoY Change 485.86% 33.28% 100.57%
Depreciation, Depletion And Amortization $7.913M $13.73K $1.031M
YoY Change 667.58% -98.67% 126.37%
Cash From Operating Activities -$4.747M -$3.953M -$5.071M
YoY Change 6.83% -22.03% 521.94%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$374.0K
YoY Change -100.0% -100.0% -77.95%
Cash From Investing Activities $0.00 $0.00 -$374.0K
YoY Change -100.0% -100.0% -77.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.019M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.831M 3.925M 5.019M
YoY Change 423.13% -21.79% 43.43%
NET CHANGE
Cash From Operating Activities -4.747M -3.953M -5.071M
Cash From Investing Activities 0.000 0.000 -374.0K
Cash From Financing Activities 4.831M 3.925M 5.019M
Net Change In Cash 83.93K -28.12K -425.6K
YoY Change -102.22% -93.39% -143.1%
FREE CASH FLOW
Cash From Operating Activities -$4.747M -$3.953M -$5.071M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31241330 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-51815
dei Entity Registrant Name
EntityRegistrantName
LOGIQ, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5057897
dei Entity Address Address Line1
EntityAddressAddressLine1
85 Broad Street
dei Entity Address Address Line2
EntityAddressAddressLine2
16-079
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89592945 usd
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10004
dei City Area Code
CityAreaCode
(808)
dei Local Phone Number
LocalPhoneNumber
829-1057
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47359024 shares
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11752801 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14797196 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
114832 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
153973 usd
CY2022Q3 us-gaap Goodwill
Goodwill
5577926 usd
CY2021Q4 us-gaap Goodwill
Goodwill
5577926 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
17445559 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
20529095 usd
CY2021Q4 lgiq Amount Due From Associate
AmountDueFromAssociate
7208700 usd
CY2022Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2955949 usd
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3966086 usd
CY2022Q3 lgiq Right To Use Assets Operating Lease
RightToUseAssetsOperatingLease
52217 usd
CY2021Q4 lgiq Right To Use Assets Operating Lease
RightToUseAssetsOperatingLease
91571 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
704583 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
804011 usd
CY2021Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
681 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
20004 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
22513 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
368274 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1563752 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
4101027 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
13657314 usd
CY2022Q3 us-gaap Assets
Assets
21546586 usd
CY2021Q4 us-gaap Assets
Assets
34186409 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3782823 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2293858 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
3290613 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1804131 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
705 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10500 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52217 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
91571 usd
CY2022Q3 us-gaap Deposit Liability Current
DepositLiabilityCurrent
188250 usd
CY2021Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
401028 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7314608 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82473004 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4601088 usd
CY2022Q3 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
10000 usd
CY2021Q4 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
10000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
7324608 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4611088 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36849696 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36849696 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26350756 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26350756 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
3685 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2635 usd
CY2022Q3 lgiq Capital Reserves
CapitalReserves
25011625 usd
CY2021Q4 lgiq Capital Reserves
CapitalReserves
29349795 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-100386277 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82250113 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
14221978 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29575321 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21546586 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34186409 usd
CY2022Q3 us-gaap Revenues
Revenues
4100373 usd
CY2021Q3 us-gaap Revenues
Revenues
7826249 usd
us-gaap Revenues
Revenues
17155733 usd
us-gaap Revenues
Revenues
24210548 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
2792499 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
5520862 usd
us-gaap Cost Of Revenue
CostOfRevenue
11823582 usd
us-gaap Cost Of Revenue
CostOfRevenue
17230056 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1307874 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
2305387 usd
us-gaap Gross Profit
GrossProfit
5332151 usd
us-gaap Gross Profit
GrossProfit
6980492 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1021676 usd
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1030932 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3083536 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2751208 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7265372 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5159813 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16504135 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14296952 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
394628 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
477226 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1266029 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1198479 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
321000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1447567 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2617178 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4010239 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
9002676 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
8115538 usd
us-gaap Operating Expenses
OperatingExpenses
23470878 usd
us-gaap Operating Expenses
OperatingExpenses
22256878 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7694802 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5810151 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-18138727 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15276386 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3 usd
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-18136164 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
36740 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2563 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
456032 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-7694799 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-5773411 usd
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-14820354 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10441 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7694799 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5773411 usd
us-gaap Net Income Loss
NetIncomeLoss
-18136164 usd
us-gaap Net Income Loss
NetIncomeLoss
-14830795 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2221
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2471
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.5808
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.7623
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34645067 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23365486 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31241330 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19455335 shares
us-gaap Net Income Loss
NetIncomeLoss
-18136164 usd
us-gaap Net Income Loss
NetIncomeLoss
-14830795 usd
us-gaap Depreciation
Depreciation
39141 usd
us-gaap Depreciation
Depreciation
39097 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3044395 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2712111 usd
us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
507068 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1010137 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
529750 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-99428 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
763326 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
1488965 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
1172292 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1486482 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
328260 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-9795 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-32659 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10977411 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12411838 usd
lgiq Increase Decrease In Amount Due From Associate
IncreaseDecreaseInAmountDueFromAssociate
-7208700 usd
lgiq Increase Decrease In Amount Due From Associate
IncreaseDecreaseInAmountDueFromAssociate
1279000 usd
lgiq Payments To Acquire Financial Assets Held For Resale
PaymentsToAcquireFinancialAssetsHeldForResale
-681 usd
lgiq Payments To Acquire Financial Assets Held For Resale
PaymentsToAcquireFinancialAssetsHeldForResale
-593582 usd
lgiq Net Restricted Cash Acquired In Acquisitions
NetRestrictedCashAcquiredInAcquisitions
7736 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7209381 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-677682 usd
lgiq Proceeds From Shares To Be Issueds
ProceedsFromSharesToBeIssueds
-212778 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2782821 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11051120 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
3910784 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2570043 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14961904 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1197987 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1872384 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1586265 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3489778 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
388278 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5362162 usd
lgiq Issuance Of Shares For Services Received
IssuanceOfSharesForServicesReceived
5969804 usd
lgiq Issuance Of Shares For Services Received
IssuanceOfSharesForServicesReceived
3501236 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29575321 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-2784618 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
13 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3980524 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
22810166 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1741423 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6460841 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
18090748 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3826029 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7694799 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
14221978 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
23903508 usd
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1420413 usd
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
6192439 usd
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1526004 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4081749 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
28960615 usd
CY2021Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3851899 usd
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1126331 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1406920 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4975635 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
30370130 usd
CY2021Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4015542 usd
CY2021Q3 lgiq Cancellation Of Shares For Proceeds
CancellationOfSharesForProceeds
-9 usd
CY2021Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2256634 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1850510 usd
CY2021Q3 lgiq Cancellation Of Shares For Service
CancellationOfSharesForService
-1281689 usd
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2911372 usd
CY2021Q3 lgiq Cancellation Of Shares For Convertible Note
CancellationOfSharesForConvertibleNote
-186 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5773411 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
34348893 usd
CY2021Q2 lgiq Issuance Of Offering Shares
IssuanceOfOfferingShares
1976434 shares
us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
3250000 usd
us-gaap Asset Acquisition Consideration Transferred Other Assets
AssetAcquisitionConsiderationTransferredOtherAssets
250000 usd
us-gaap Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
2912621 shares
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
500000 usd
CY2022Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
26350756 shares
CY2022Q1 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
The Company held the GoLogiq Shares until it distributed 100% of the GoLogiq Shares to the Company’s stockholders of record as of December 30, 2021 on a 1-for-1 basis (i.e. for every 1 share of Logiq held on December 30, 2021, the holder thereof will receive 1 share of Lovarra) upon completion of the Distribution.
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.122 pure
lgiq Operating Segments
OperatingSegments
0.10 pure
lgiq Data Logiq Spinoff Description
DataLogiqSpinoffDescription
At Closing Abri will deliver to the Company $114 million worth of shares Abri common stock, par value $0.0001, at $10.00 per share (the “Merger Consideration Shares”). Also at Closing, the Company will issue a dividend to its shareholders on a pro-rata basis equal to 25% of the aggregate Merger Consideration Shares (the “Dividend Shares”), payable to the Company shareholders of record as of a record date to be set shortly before Closing.
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">USE OF ESTIMATES</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the Company’s financial statements in conformity with generally accepted accounting principles of the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management makes its best estimate of the ultimate outcome for these items based on historical trends and other information available when the financial statements are prepared. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
lgiq Amortization Of Intangible Assets Net
AmortizationOfIntangibleAssetsNet
3044395 usd
lgiq Amortization Of Intangible Assets Net
AmortizationOfIntangibleAssetsNet
2712111 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ACCOUNTS RECEIVABLE AND CONCENTRATION OF RISK</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable consists of trade receivables from customers. The Company records accounts receivable at its net realizable value, recognizing an allowance for doubtful accounts based on our best estimate of probable credit losses on our existing accounts receivable. Balances are written off against the allowance after all means of collection have been exhausted and the possibility of recovery is considered remote.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2022 and 2021, the allowance for bad debt was approximately $155,592 and $54,619, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
155592 usd
us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
54619 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21603721 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21603721 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6806525 usd
lgiq Charge For Period For Intangible Assets
ChargeForPeriodForIntangibleAssets
3044395 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9850920 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11752801 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14797196 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1017204 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1017204 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3044395 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2712111 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1024416 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4068811 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4068811 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2251265 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
339498 usd
CY2022Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
11752801 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
253362 usd
CY2022Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
3111541 usd
CY2021Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4121678 usd
lgiq Allowance For Doubtful Debts
AllowanceForDoubtfulDebts
-155592 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
253362 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
99389 usd
lgiq Charge For Period
ChargeForPeriod
39141 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
138530 usd
CY2022Q3 lgiq Net Property And Equipments
NetPropertyAndEquipments
114832 usd
CY2021Q4 lgiq Net Property And Equipment
NetPropertyAndEquipment
153973 usd
CY2022Q3 us-gaap Depreciation
Depreciation
13728 usd
CY2021Q3 us-gaap Depreciation
Depreciation
13729 usd
us-gaap Depreciation
Depreciation
39141 usd
us-gaap Depreciation
Depreciation
39097 usd
CY2022Q3 us-gaap Goodwill Gross
GoodwillGross
5577926 usd
CY2021Q4 us-gaap Goodwill Gross
GoodwillGross
5577926 usd
CY2022Q3 us-gaap Goodwill
Goodwill
5577926 usd
CY2021Q4 us-gaap Goodwill
Goodwill
5577926 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
155592 usd
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
54619 usd
CY2021 lgiq Allowance For Doubtful Debts
AllowanceForDoubtfulDebts
-155592 usd
lgiq Recoveries For Accounts Receivable
RecoveriesForAccountsReceivable
2955949 usd
CY2021 lgiq Recoveries For Accounts Receivable
RecoveriesForAccountsReceivable
3966086 usd
CY2021 lgiq Accounts Receivable Provision For Bad Debts
AccountsReceivableProvisionForBadDebts
100973 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
155592 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
155592 usd
CY2022Q3 us-gaap Trade Receivables Held For Sale Amount
TradeReceivablesHeldForSaleAmount
2955949000000 usd
CY2021Q4 us-gaap Retail Land Sales Receivables Stated Interest Rate
RetailLandSalesReceivablesStatedInterestRate
1 pure
CY2018Q2 us-gaap Equity Method Investment Additional Information
EquityMethodInvestmentAdditionalInformation
On April 23, 2018, the Company participated in the incorporation of a company in Indonesia, PT Weyland Indonesia Perkasa (“WIP’), an Indonesian limited liability company of which the Company held a 49% equity interest with the option to purchase an additional 31% equity interest at a later date.
CY2018Q2 lgiq Investment Ownership Percentage
InvestmentOwnershipPercentage
0.49 pure
CY2019Q2 us-gaap Equity Method Investment Additional Information
EquityMethodInvestmentAdditionalInformation
In April 2019, the Company completed the distribution as a dividend in specie, to the Company’s shareholders of record at October 12, 2018 of its 49% equity interest in WIP to Weyland AtoZPay Inc. and now holds an equitable interest of 31% in WIP.
us-gaap Equity Method Investment Additional Information
EquityMethodInvestmentAdditionalInformation
The Company held a 31% unexercised option in WIP as of December 31, 2018. Due to the continuing legal restructuring in Indonesia, all the conditions precedent had not been satisfied and the 31% option had not been exercised as of September 30, 2022.
CY2021Q4 us-gaap Due From Related Parties
DueFromRelatedParties
7208700 usd
CY2021Q4 lgiq Total Due From Related Parties
TotalDueFromRelatedParties
7208700 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2022Q3 lgiq Deposit And Other Receivable
DepositAndOtherReceivable
472401 usd
CY2021Q4 lgiq Deposit And Other Receivable
DepositAndOtherReceivable
400801 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
232182 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
403210 usd
CY2022Q3 lgiq Prepayments Deposits And Other Receivables
PrepaymentsDepositsAndOtherReceivables
704583 usd
CY2021Q4 lgiq Prepayments Deposits And Other Receivables
PrepaymentsDepositsAndOtherReceivables
804011 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3290613 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1804131 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3290613 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1804131 usd
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.21 pure
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.21 pure
CY2021Q3 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.34 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2015Q4 us-gaap Profit Loss
ProfitLoss
733721 usd
CY2014Q4 us-gaap Profit Loss
ProfitLoss
-255693 usd
CY2015Q4 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.398 pure
CY2014Q4 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.398 pure
CY2015Q4 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
292201 usd
CY2014Q4 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-101765 usd
CY2015Q4 lgiq Tax Losses Carryforward Deferred
TaxLossesCarryforwardDeferred
-292201 usd
CY2014Q4 lgiq Tax Losses Carryforward Deferred
TaxLossesCarryforwardDeferred
101765 usd
us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
2619205 usd
CY2014 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
3352926 usd
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2619205 usd
CY2014Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
3352926 usd
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2619205 usd
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3352926 usd
CY2015Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.398 pure
CY2014Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.398 pure
CY2015Q4 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1042444 usd
CY2014Q4 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1334465 usd
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1042444 usd
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1334465 usd
CY2020Q2 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
503700 usd
CY2021Q2 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
503700 usd
CY2020Q1 lgiq Certificate Of Amendment Description
CertificateOfAmendmentDescription
On February 25, 2020, the Company filed a certificate of amendment (the “Certificate of Amendment”) to the Company’s Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware, to effect a reverse stock split of the Company’s common stock, $0.0001 par value per share, at a rate of approximately 1-for-13 (the “Reverse Stock Split”). 
lgiq Certificate Of Amendment Description
CertificateOfAmendmentDescription
Upon the filing of the Certificate of Amendment, and the resulting effectiveness of the Reverse Stock Split, every 13 outstanding shares of the Company’s common stock were, without any further action by the Company, or any holder thereof, combined into and automatically became 1 share of the Company’s Common Stock.
lgiq Merger Agreement Description
MergerAgreementDescription
As consideration for the Merger, the Company delivered to those persons set forth in the Merger Agreement an aggregate total cash payment of $1,126,000 (the “Cash Consideration”), and an aggregate number of restricted shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), equal to (i) (x) $7,000,000, divided by (ii) the volume weighted average closing price of the Company’s Common Stock for the twenty consecutive trading days prior to Closing (the “Stock Consideration,” and together with the Cash Consideration, the “Merger Consideration”), subject in each case to adjustment as provided in the Merger Agreement. Notwithstanding the foregoing, pursuant to the terms of the Merger Agreement, (i) a portion of the Cash Consideration, in an amount equal to the outstanding balance of that PPP Loan made to Rebel AI in January 2021, shall be withheld at Closing and placed into an escrow account, pending forgiveness or repayment of the PPP Loan, as applicable, and (ii) $2,000,000 of Common Stock shall be withheld from the Stock Consideration and deposited into an escrow account, pending release in accordance with the terms of the Merger Agreement.
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1126000 usd
CY2022Q3 lgiq Per Share
PerShare
0.0001 shares
CY2021Q1 lgiq Issuances Of Common Stock
IssuancesOfCommonStock
100000 shares
CY2021Q1 lgiq Offering Price Per Share
OfferingPricePerShare
5
lgiq Offering Expenses
OfferingExpenses
500000 usd
CY2021Q2 lgiq Agency Agreement Description
AgencyAgreementDescription
On June 9, 2021, Logiq entered into an Agency Agreement (the “Agency Agreement”) with Research Capital Corporation (the “Agent”) relating to the offering (the “Offering”) by the Company of a minimum of 1,666,667 units of securities (each, a “Unit”), and a maximum of 3,333,333 Units, at a price of C$3.00 per Unit (the “Offering Price”), for minimum gross proceeds of C$5,000,000, and maximum gross proceeds of C$10,000,000. Each Unit consists of (i) one share of common stock of the Company, par value $0.0001 per share (and the Common Stock included in a Unit being a “Unit Share”), and (ii) one Common Stock purchase warrant (each, a “Warrant”), where each Warrant entitles the holder thereof to acquire one share of Common Stock (each, a “Warrant Share”) at an exercise price of C$3.50 per Warrant Share, subject to adjustment, at any time before the third anniversary (the “Warrant Expiry Date”) of June 17, 2021 (the “Closing Date”). 
lgiq Aggregate Gross Proceeds Percentage
AggregateGrossProceedsPercentage
0.08 pure
lgiq Warrant Description
WarrantDescription
Pursuant to the terms of the Agency Agreement, the Company also agreed to grant the Agent an option (the “Over-Allotment Option”), exercisable in whole or in part, at the sole discretion of the Agent, at any time up to 30 days following the Closing Date, to purchase from the Company: (i) up to such additional number of Units (the “Over-Allotment Units”) equal to 15% of the number of Units sold under the Offering (the “Over-Allotment Number”) at the Offering Price; (ii) up to such number of additional Warrants (the “Over-Allotment Warrants”) equal to 15% of the number of Warrants comprising the Units sold under the Offering at C$0.4898 per Over-Allotment Warrant; (iii) up to such number of additional shares of Common Stock (the “Over-Allotment Unit Shares”) equal to 15% of the number of shares of Common Stock comprising the Units sold under the Offering at C$2.5102 per Over-Allotment Unit Share; or (iv) any combination of Over-Allotment Units, Over-Allotment Warrants, and Over-Allotment Unit Shares, so long as the aggregate number of Over-Allotment Units, Over-Allotment Warrants, and Over-Allotment Unit Shares does not comprise together more than what is included in the Over-Allotment Number of Over-Allotment Units.
CY2021Q3 lgiq Exercise Price
ExercisePrice
2.85
CY2021Q4 us-gaap Shares Issued
SharesIssued
106041 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 lgiq Arithmetic Average Purchase Of Shares Percentage
ArithmeticAveragePurchaseOfSharesPercentage
0.97 pure
CY2022Q1 lgiq Warrants To Purchase Of Common Stock
WarrantsToPurchaseOfCommonStock
631579 shares
CY2022Q1 lgiq Common Stock Percentage
CommonStockPercentage
0.015 pure
CY2022Q1 us-gaap Other Commitment
OtherCommitment
40000000 usd
CY2022Q1 lgiq Ownership Limitation Percentage
OwnershipLimitationPercentage
0.0999 pure
CY2022Q1 us-gaap Stock Issued1
StockIssued1
37000000 usd
us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
3250000 usd
us-gaap Asset Acquisition Consideration Transferred Other Assets
AssetAcquisitionConsiderationTransferredOtherAssets
250000 usd
us-gaap Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
2912621 shares
CY2022Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
2951080 shares
CY2022Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
4231824 shares
CY2022Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
3448362 shares
CY2022Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
35714285 shares
CY2020Q4 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
5000000 usd
CY2020Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
14284714 usd
CY2020Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.0001
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
564467 shares
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q3 lgiq Total Shares Of Common Stock
TotalSharesOfCommonStock
51762839 shares
CY2022Q1 us-gaap Shares Issued
SharesIssued
25080 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Shares Issued
SharesIssued
1017286 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Shares Issued
SharesIssued
2246150 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
132320 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
6 shares
CY2022Q3 us-gaap Share Price
SharePrice
0.0001
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
132320 shares
CY2022Q1 lgiq Issuance Of Common Stock
IssuanceOfCommonStock
25080 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
1017286 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
2246150 shares
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7694799 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5773411 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18136164 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14830795 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
923 usd
lgiq Maturity Date
MaturityDate
2022-12-31
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
693000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
52217 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
91571 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
240095 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
367200 usd
lgiq Remaining Lease Term
RemainingLeaseTerm
3 months
CY2021 lgiq Remaining Lease Term
RemainingLeaseTerm
1 years
CY2022Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0325 pure
CY2021Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.015 pure
CY2022Q3 lgiq Operating Leases Future Minimum Payment Due
OperatingLeasesFutureMinimumPaymentDue
52500 usd
CY2022Q3 us-gaap Receivable With Imputed Interest Net Amount
ReceivableWithImputedInterestNetAmount
283 usd
CY2022Q3 lgiq Total Lease Liability
TotalLeaseLiability
52217 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
lgiq Revenues Percentage
RevenuesPercentage
0.10 pure
lgiq Revenues Percentage
RevenuesPercentage
0.10 pure
CY2022Q3 lgiq Revenues Percentage
RevenuesPercentage
0.10 pure
CY2021Q3 lgiq Revenues Percentage
RevenuesPercentage
0.09 pure
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4100373 usd
CY2022Q3 lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1 pure
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7826249 usd
CY2021Q3 lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17155733 usd
lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24210548 usd
lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1 pure
CY2022Q1 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
3000000 usd
CY2022Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
2926000 shares
CY2022Q3 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
1750000 shares
CY2022Q3 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
1750000 shares
us-gaap Legal Fees
LegalFees
25000 usd
CY2022Q3 lgiq Amount Due From Associate
AmountDueFromAssociate
usd
CY2022Q3 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
usd
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.2471
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.5808
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.7623
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.2224
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19455335 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23365486 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34645067 shares
us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
usd
lgiq Net Restricted Cash Acquired In Acquisitions
NetRestrictedCashAcquiredInAcquisitions
usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
lgiq Additions On Intangible Assets
AdditionsOnIntangibleAssets
usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
usd
CY2022Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
usd
CY2021Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
usd
lgiq Accounts Receivable Provision For Bad Debts
AccountsReceivableProvisionForBadDebts
usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
usd
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
usd
CY2022Q3 us-gaap Due From Related Parties
DueFromRelatedParties
usd
CY2022Q3 lgiq Total Due From Related Parties
TotalDueFromRelatedParties
usd
CY2015Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2014Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
usd
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
usd
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001335112

Files In Submission

Name View Source Status
0001213900-22-072397-index-headers.html Edgar Link pending
0001213900-22-072397-index.html Edgar Link pending
0001213900-22-072397.txt Edgar Link pending
0001213900-22-072397-xbrl.zip Edgar Link pending
ex10-2_001.jpg Edgar Link pending
f10q0922ex10-1_cinedigmcorp.htm Edgar Link pending
f10q0922ex10-2_cinedigmcorp.htm Edgar Link pending
f10q0922ex31-1_logiqinc.htm Edgar Link pending
f10q0922ex31-2_logiqinc.htm Edgar Link pending
f10q0922ex32-1_logiqinc.htm Edgar Link pending
f10q0922_logiqinc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lgiq-20220930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
lgiq-20220930_def.xml Edgar Link unprocessable
f10q0922_logiqinc_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lgiq-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
lgiq-20220930_cal.xml Edgar Link unprocessable
lgiq-20220930_lab.xml Edgar Link unprocessable